Aris Persidis is Co-Founder and President of Biovista, the Big Data/AI drug repositioning and personalized medicine pioneer. Prior to Biovista, Aris was SVP, Research and Business Development, at Upstate (acquired by Serologicals), and was co-founder of Cellzome (acquired by GSK), Anadys (acquired by Roche), and RheoGene (acquired by Intrexon). Aris holds a Ph.D. in biochemistry from the University of Cambridge.